Clear differences in adiponectin level and glutathione redox status revealed in obese and normal-weight patients with psoriasis

被引:84
作者
Kaur, S. [1 ]
Zilmer, K. [2 ]
Kairane, C. [2 ]
Kals, M. [3 ]
Zilmer, M. [2 ]
机构
[1] Univ Tartu, Dermatol Clin, EE-50417 Tartu, Estonia
[2] Univ Tartu, Inst Biochem, EE-50417 Tartu, Estonia
[3] AS Resta, EE-51014 Tartu, Estonia
关键词
adiponectin; glutathione redox ratio; IL-6; obesity; psoriasis;
D O I
10.1111/j.1365-2133.2008.08759.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
Several studies have shown increased prevalence of obesity in patients with psoriasis. To characterize both inflammatory- and oxidative stress-related differences between obese patients with psoriasis (OPP) and normal-weight patients with psoriasis (NWPP). The plasma concentrations of adiponectin and interleukin (IL)-6 were analysed by quantitative sandwich enzyme immunoassay technique in 10 patients with a body mass index (BMI) < 25 and 12 patients with a BMI > 30. Total glutathione and oxidized glutathione levels were measured spectrophotometrically. Plasma concentration of adiponectin in NWPP was more than twice the level in healthy normal-weight controls (P < 0.001), while such an elevation did not occur in OPP. OPP were characterized by a significantly increased IL-6 level, which correlated negatively with the adiponectin level (r = -0.85, P < 0.001). The glutathione redox status, which was also inversely correlated with the adiponectin level (r = -0.63, P < 0.05), was associated with significantly increased oxidative stress in the OPP compared with the NWPP or controls. Obesity in patients with psoriasis is associated with both decreased plasma levels of protective adiponectin compared with NWPP, and enhanced systemic inflammation and oxidative stress. These findings are in concordance with high prevalence of diseases related to lower adiponectin levels among psoriasis patients.
引用
收藏
页码:1364 / 1367
页数:4
相关论文
共 15 条
[1]
Annuk M, 2001, J AM SOC NEPHROL, V12, P2747, DOI 10.1681/ASN.V12122747
[2]
Serum levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17 and IL-18 in patients with active psoriasis and correlation with disease severity [J].
Arican, O ;
Aral, M ;
Sasmaz, S ;
Ciragil, P .
MEDIATORS OF INFLAMMATION, 2005, (05) :273-279
[3]
Adipose tissue, adipokines, and inflammation [J].
Fantuzzi, G .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 115 (05) :911-919
[4]
Psoriasis 1 - Pathogenesis and clinical features of psoriasis [J].
Griffiths, Christopher E. M. ;
Barker, Jonathan N. W. N. .
LANCET, 2007, 370 (9583) :263-271
[5]
DISEASE CONCOMITANCE IN PSORIASIS [J].
HENSELER, T ;
CHRISTOPHERS, E .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 32 (06) :982-986
[6]
Impact of obesity and smoking on psoriasis presentation and management [J].
Herron, MD ;
Hinckley, M ;
Hoffman, MS ;
Papenfuss, J ;
Hansen, CB ;
Callis, KP ;
Krueger, GG .
ARCHIVES OF DERMATOLOGY, 2005, 141 (12) :1527-1534
[7]
The role of the adipocyte hormone adiponectin in cardiovascular disease [J].
Hug, C ;
Lodish, HF .
CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (02) :129-134
[8]
The emerging role of adipokines as mediators of inflammation and immune responses [J].
Lago, Francisca ;
Dieguez, Carlos ;
Gomez-Reino, Juan ;
Gualillo, Oreste .
CYTOKINE & GROWTH FACTOR REVIEWS, 2007, 18 (3-4) :313-325
[9]
Role of increased production of monocytes TNF-alpha, IL-1 beta and IL-6 in psoriasis: Relation to focal infection, disease activity and responses to treatments [J].
Mizutani, H ;
Ohmoto, Y ;
Mizutani, T ;
Murata, M ;
Shimizu, M .
JOURNAL OF DERMATOLOGICAL SCIENCE, 1997, 14 (02) :145-153
[10]
Sies H., 2007, ENCY STRESS, P45, DOI DOI 10.1016/B978-012373947-6.00285-3